277 related articles for article (PubMed ID: 31711978)
1. Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia.
Chen L; Li XS; Zheng GE; Xie GJ; Cheng Y
Neurosci Lett; 2020 Jan; 714():134618. PubMed ID: 31711978
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
Reinhart V; Bove SE; Volfson D; Lewis DA; Kleiman RJ; Lanz TA
Neurobiol Dis; 2015 May; 77():220-7. PubMed ID: 25796564
[TBL] [Abstract][Full Text] [Related]
3. TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level.
Yeo IJ; Yu JE; Kim SH; Kim DH; Jo M; Son DJ; Yun J; Han SB; Hong JT
Arch Pharm Res; 2024 Apr; 47(4):341-359. PubMed ID: 38592583
[TBL] [Abstract][Full Text] [Related]
4. Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders.
Ray MT; Shannon Weickert C; Webster MJ
Transl Psychiatry; 2014 May; 4(5):e389. PubMed ID: 24802307
[TBL] [Abstract][Full Text] [Related]
5. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
6. Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia.
Li XS; Wu HT; Yu Y; Chen GY; Qin XY; Zheng GE; Deng W; Cheng Y
Neurosci Lett; 2018 Nov; 686():28-32. PubMed ID: 30172685
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
Li Z; Zhang C; Fan J; Yuan C; Huang J; Chen J; Yi Z; Wang Z; Hong W; Wang Y; Lu W; Guan Y; Wu Z; Su Y; Cao L; Hu Y; Hao Y; Liu M; Yu S; Cui D; Xu L; Song Y; Fang Y
Br J Psychiatry; 2014 Jul; 205(1):29-35. PubMed ID: 24764546
[TBL] [Abstract][Full Text] [Related]
8. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of blood proBDNF and its receptors in major depression.
Zhou L; Xiong J; Lim Y; Ruan Y; Huang C; Zhu Y; Zhong JH; Xiao Z; Zhou XF
J Affect Disord; 2013 Sep; 150(3):776-84. PubMed ID: 23537780
[TBL] [Abstract][Full Text] [Related]
10. Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Çakici N; Sutterland AL; Penninx BWJH; de Haan L; van Beveren NJM
Psychol Med; 2021 Mar; 51(4):538-549. PubMed ID: 33653423
[TBL] [Abstract][Full Text] [Related]
11. Lower serum tropomyosin receptor kinase B levels in patients with schizophrenia.
Hung YY; Huang TL
Biomed J; 2013; 36(3):132-6. PubMed ID: 23806883
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder.
Tripp A; Oh H; Guilloux JP; Martinowich K; Lewis DA; Sibille E
Am J Psychiatry; 2012 Nov; 169(11):1194-202. PubMed ID: 23128924
[TBL] [Abstract][Full Text] [Related]
13. Elevated TREM2 mRNA expression in leukocytes in schizophrenia but not major depressive disorder.
Yoshino Y; Kawabe K; Yamazaki K; Watanabe S; Numata S; Mori Y; Yoshida T; Iga J; Ohmori T; Ueno S
J Neural Transm (Vienna); 2016 Jun; 123(6):637-41. PubMed ID: 27130565
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.
Qin XY; Wu HT; Cao C; Loh YP; Cheng Y
Mol Psychiatry; 2017 Sep; 22(9):1306-1312. PubMed ID: 28070123
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls.
Chiou YJ; Huang TL
PLoS One; 2019; 14(2):e0212373. PubMed ID: 30794585
[TBL] [Abstract][Full Text] [Related]
16. The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment.
Jiang H; Chen S; Li C; Lu N; Yue Y; Yin Y; Zhang Y; Zhi X; Zhang D; Yuan Y
Transl Psychiatry; 2017 Apr; 7(4):e1079. PubMed ID: 28375203
[TBL] [Abstract][Full Text] [Related]
17. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.
Hashimoto T; Bergen SE; Nguyen QL; Xu B; Monteggia LM; Pierri JN; Sun Z; Sampson AR; Lewis DA
J Neurosci; 2005 Jan; 25(2):372-83. PubMed ID: 15647480
[TBL] [Abstract][Full Text] [Related]
18. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.
Yoshida T; Ishikawa M; Niitsu T; Nakazato M; Watanabe H; Shiraishi T; Shiina A; Hashimoto T; Kanahara N; Hasegawa T; Enohara M; Kimura A; Iyo M; Hashimoto K
PLoS One; 2012; 7(8):e42676. PubMed ID: 22880079
[TBL] [Abstract][Full Text] [Related]
20. Low serum brain-derived neurotrophic factor is associated with suicidal ideation in major depressive disorder.
Khan MS; Wu GWY; Reus VI; Hough CM; Lindqvist D; Westrin Å; Nier BM; Wolkowitz OM; Mellon SH
Psychiatry Res; 2019 Mar; 273():108-113. PubMed ID: 30640051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
